Lake Street Maintains Buy on Sensus Healthcare, Lowers Price Target to $4
Lake Street analyst Ben Haynor maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target from $4.5 to $4.
Stocks · News reference
Sensus Healthcare Q2 EPS $(0.53) Misses $(0.13) Estimate, Sales $2.290M Miss $4.601M Estimate
Sensus Healthcare (NASDAQ:SRTS) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.13) by 341.67 percent. This is a 783.33 percent decrease over losses of $(0.06) per share
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Applied Materials, Globant And 3 Stocks To Watch Heading Into Friday
U.S. stock futures mixed, investors eye Suncrete Inc's quarterly loss. Applied Materials beats expectations, Bally's Corp to release earnings.
Full Transcript: Sensus Healthcare Q2 2026 Earnings Call
Sensus Healthcare (NASDAQ:SRTS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive
Sensus Healthcare shares are trading lower after the company reported worse-than-expected Q2 financial results.